We are live on ! Find out more
FCP

Fidelis Capital Partners Portfolio holdings

AUM $1.4B
1-Year Est. Return 31.16%
This Fund
S&P 500
This Quarter Est. Return
+3.08%
1 Year Est. Return
+31.16%
3 Year Est. Return
+98.29%
5 Year Est. Return
10 Year Est. Return
AUM
$1B
AUM Growth
+$160M
Cap. Flow
+$123M
Cap. Flow %
12.26%
Top 10 Hldgs %
33.3%
Holding
459
New
47
Increased
265
Reduced
100
Closed
20

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$9.7M
2
AMD icon
Advanced Micro Devices
AMD
+$1.11M
3
AZN icon
AstraZeneca
AZN
+$1.02M
4
ELV icon
Elevance Health
ELV
+$1.01M
5
C icon
Citigroup
C
+$923K

Sector Composition

Rank Sector Weight
1 Technology 20.6%
2 Financials 9.23%
3 Consumer Discretionary 7.09%
4 Communication Services 6.43%
5 Healthcare 5.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTC icon
351
PTC
PTC
$16B
$276K 0.03%
1,453
-6
-0.4% -$1.14K
TTD icon
352
Trade Desk
TTD
$6.49B
$276K 0.03%
+2,336
New +$289K
WRB icon
353
W.R. Berkley
WRB
$26.6B
$274K 0.03%
4,598
-333
-7% -$19.9K
IBKR icon
354
Interactive Brokers
IBKR
$39.8B
$272K 0.03%
+4,860
New +$205K
NRG icon
355
NRG Energy
NRG
$24.8B
$270K 0.03%
2,625
+165
+7% +$15.3K
COO icon
356
Cooper Companies
COO
$14.5B
$267K 0.03%
2,803
-52
-2% -$5.3K
RMD icon
357
ResMed
RMD
$30.7B
$267K 0.03%
1,110
+11
+1% +$2.65K
TOL icon
358
Toll Brothers
TOL
$14.5B
$266K 0.03%
+2,020
New +$300K
TYL icon
359
Tyler Technologies
TYL
$12.8B
$265K 0.03%
440
-42
-9% -$25.4K
CTRA
360
DELISTED
Coterra Energy
CTRA
$263K 0.03%
9,385
+255
+3% +$6.34K
CME icon
361
CME Group
CME
$94.8B
$263K 0.03%
1,093
+126
+13% +$29K
TRV icon
362
Travelers Companies
TRV
$80.2B
$263K 0.03%
1,075
+69
+7% +$17.2K
PTLC icon
363
Pacer Trendpilot US Large Cap ETF
PTLC
$3.37B
$260K 0.03%
4,775
HUM icon
364
Humana
HUM
$46.2B
$259K 0.03%
+885
New +$237K
BDX icon
365
Becton Dickinson
BDX
$48.2B
$259K 0.03%
1,047
+38
+4% +$8.77K
WES icon
366
Western Midstream Partners
WES
$19.3B
$256K 0.03%
+6,300
New +$243K
GRMN
367
Garmin
GRMN
$60B
$254K 0.03%
+1,181
New +$232K
IJJ icon
368
iShares S&P Mid-Cap 400 Value ETF
IJJ
$9.03B
$253K 0.03%
1,975
-78
-4% -$9.96K
WEC icon
369
WEC Energy
WEC
$35.1B
$248K 0.02%
2,468
+83
+3% +$8.05K
CCJ icon
370
Cameco
CCJ
$42.4B
$248K 0.02%
5,223
-743
-12% -$40.5K
EXPD icon
371
Expeditors International
EXPD
$23.2B
$248K 0.02%
2,237
-101
-4% -$12.1K
LPLA icon
372
LPL Financial
LPLA
$28.6B
$246K 0.02%
+676
New +$200K
FXL icon
373
First Trust Technology AlphaDEX Fund
FXL
$2.79B
$243K 0.02%
1,564
AIG icon
374
American International
AIG
$41.3B
$243K 0.02%
3,323
+397
+14% +$29.9K
CAH icon
375
Cardinal Health
CAH
$55.4B
$242K 0.02%
+1,934
New +$226K

Similar funds

Fidelis Capital Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Fidelis Capital Partners held 459 positions worth $1B, up 19% from $840M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Fidelis Capital Partners deployed $123M of net new capital in Q4 2024, opening 47 new positions and adding to 265 existing holdings. Its largest new stake was State Street SPDR Dow Jones Industrial Average ETF Trust: 4,402 shares worth $1.96M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Lam Research, an estimated $9.7M trimmed.

  • Fidelis Capital Partners's largest Q4 2024 buy was State Street SPDR Dow Jones Industrial Average ETF Trust: 4,402 shares worth $1.96M.
  • Fidelis Capital Partners added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $12.1M increase.
  • Fidelis Capital Partners's biggest Q4 2024 reduction was Lam Research, cutting an estimated $9.7M.
  • Fidelis Capital Partners fully exited BP in Q4 2024, selling an estimated $490K.
  • Fidelis Capital Partners's ten largest holdings make up 33% of its $1B portfolio in Q4 2024.
  • Fidelis Capital Partners opened 47 new positions and closed 20 in Q4 2024.
  • Fidelis Capital Partners's portfolio value rose 19% quarter-over-quarter to $1B.

Based on Fidelis Capital Partners's 13F filing for Q4 2024, filed 6 Feb 2025.